Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Apellis Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Apellis Pharmaceuticals

Apellis Pharmaceuticals

Public

US-based Apellis Pharmaceuticals develops therapeutic compounds for autoimmune and inflammatory diseases globally.

HQ
Waltham, MA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Apellis Pharmaceuticals, based in Crestwood, United States, is a clinical-stage biopharmaceutical company dedicated to discovering and developing therapeutic compounds for autoimmune and inflammatory diseases. The company focuses on leveraging complement science to create innovative treatments that address the needs of patients worldwide.

Apellis has achieved significant milestones, including securing two approvals in less than two years, underscoring its commitment to advancing medical innovation. The company emphasizes patient advocacy by integrating community voices into its development processes, aiming to transform treatment for a broad range of debilitating diseases.

Apellis Pharmaceuticals - Similar Companies

Appello Pharmaceuticals logo

Appello Pharmaceuticals

appellopharma.com

Argentis Pharmaceuticals logo

Argentis Pharmaceuticals

argentisrx.com

Aclaris Therapeutics logo

Aclaris Therapeutics

aclaristx.com

Catalyst Pharmaceuticals logo

Catalyst Pharmaceuticals

catalystpharma.com

Osprey Pharmaceuticals USA logo

Osprey Pharmaceuticals USA

ospreypharma.com

Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

amylyx.com

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

Aristea Therapeutics logo

Aristea Therapeutics

Epirus Biopharmaceuticals logo

Epirus Biopharmaceuticals

Bristol Myers Squibb logo

Bristol Myers Squibb

bms.com

Apricus Biosciences logo

Apricus Biosciences

Apexian Pharmaceuticals logo

Apexian Pharmaceuticals

apexianpharma.com

Anthera Pharmaceuticals logo

Anthera Pharmaceuticals

anthera.com

Corbus Pharmaceuticals Holdings logo

Corbus Pharmaceuticals Holdings

corbuspharma.com

Rapt Therapeutics logo

Rapt Therapeutics

rapt.com

Apellis Pharmaceuticals - Quick Facts

Who are Apellis Pharmaceuticals' competitors?

Companies similar to Apellis Pharmaceuticals include Appello Pharmaceuticals, Argentis Pharmaceuticals, Aclaris Therapeutics and Catalyst Pharmaceuticals.

When was Apellis Pharmaceuticals founded?

Apellis Pharmaceuticals was founded in 2008.

Where is Apellis Pharmaceuticals' headquarters located?

Apellis Pharmaceuticals' headquarters is located in Waltham, MA, US.

How much has Apellis Pharmaceuticals raised to-date?

As of Jan 1, 2020, Apellis Pharmaceuticals has raised a total of $168.5M (USD).

How many employees does Apellis Pharmaceuticals have?

Apellis Pharmaceuticals has 500 employees as of Feb 6, 2024.

Apellis Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
  • Therapeutics
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research